You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?
Herantis Pharma as an Investment | Company Night Dec. 13, 2022
![](https://www.inderes.se/cdn-cgi/image/format=auto,width=128,height=128,quality=90,fit=cover/https://content.inderes.se/assets/0ebc676c-8b99-40af-886f-ac15f3f60174.png)
Af Inderes
Antti Vuolanto, CEO, talks about Herantis Pharma as an investment.
Health Technology & Pharmaceutical Developer Night:
Keynote – Antti Siltanen, Inderes (link)
Faron – Markku Jalkanen, CEO (link)
Aiforia – Jukka Tapaninen, CEO (link)
Optomed – Seppo Kopsala, CEO (link)
Herantis Pharma – Antti Vuolanto, CEO (link)
BBS – Ilkka Kangasniemi, CEO (link)
Bioretec – Timo Lehtonen, CEO (link)
Health Technology & Pharmaceutical Developer Night on inderesTV (link)